Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Khanna, Madhu ^a   Sharma, Sachin ^a   Kumar, Binod ^a   Rajput, Roopali ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; DNA VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; TOLL LIKE RECEPTOR 2; HEMAGGLUTININ;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; BACTERIAL LOAD; CELLULAR IMMUNITY; CROSS PROTECTION; CROSS REACTION; HUMORAL IMMUNITY; IMMUNITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; NONHUMAN; POINT MUTATION; REVIEW; SEASONAL INFLUENZA; VACCINE PRODUCTION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS REPLICATION; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

ANIMALS; CONSERVED SEQUENCE; HEMAGGLUTININS; HUMANS; IMMUNITY; INFLUENZA VACCINES; INFLUENZA, HUMAN; PROTEIN STRUCTURE, TERTIARY; VACCINES, DNA;

EID: 84902166999     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/546274     Document Type: Review

References (41)

1. Tong S., Zhu X., Li Y., Shi M., Zhang J., Bourgeois M., New world bats harbor diverse influenza A viruses. PLoS Pathogens 2013 9 10 1 12
2. Zhu X., Yu W., McBride R., Li Y., Chen L.-M., Donis R. O., Tong S., Paulson J. C., Wilson I. A., Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proceedings of the National Academy of Sciences of the United States of America 2013 110 4 1458 1463 2-s2.0-84872831242 10.1073/pnas.1218509110
3. Taubenberger J. K., Morens D. M., 1918 Influenza: the mother of all pandemics. Emerging Infectious Diseases 2006 12 1 15 22 2-s2.0-31344482504 (Pubitemid 43143529)
4. Guan Y., Vijaykrishna D., Bahl J., Zhu H., Wang J., Smith G. J. D., The emergence of pandemic influenza viruses. Protein and Cell 2010 1 1 9 13 2-s2.0-79953140489 10.1007/s13238-010-0008-z
5. Khanna M., Saxena L., Gupta A., Kumar B., Rajput R., Influenza pandemics of 1918 and 2009: a comparative account. Future Virology 2013 8 4 335 342 2-s2.0-84876134239 10.2217/fvl.13.18
6. Goldsmith C., It's just the flu. Influenza: The Next Pande Mic? 2007 Minneapolis, Minn, USA Twenty-First Century Books Edited by C. Goldsmith
7. Ekiert D. C., Bhabha G., Elsliger M.-A., Friesen R. H. E., Jongeneelen M., Throsby M., Goudsmit J., Wilson I. A., Antibody recognition of a highly conserved influenza virus epitope. Science 2009 324 5924 246 251 2-s2.0-64849114224 10.1126/science.1171491
8. Belser J. A., Lu X., Maines T. R., Smith C., Li Y., Donis R. O., Katz J. M., Tumpey T. M., Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of eurasian H7N7 viruses isolated from humans. Journal of Virology 2007 81 20 11139 11147 2-s2.0-35148894468 10.1128/JVI.01235-07 (Pubitemid 47536086)
9. Lin Y. P., Shaw M., Gregory V., Cameron K., Lim W., Klimov A., Subbarao K., Guan Y., Krauss S., Shortridge K., Webster R., Cox N., Hay A., Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proceedings of the National Academy of Sciences of the United States of America 2000 97 17 9654 9658 2-s2.0-12944270582 (Pubitemid 30650831)
10. Claas E. C. J., Osterhaus A. D. M. E., Van Beek R., De Jong J. C., Rimmelzwaan G. F., Senne D. A., Krauss S., Shortridge K. F., Webster R. G., Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998 351 9101 472 477 2-s2.0-0032515638 10.1016/S0140-6736(97) 11212-0 (Pubitemid 28070093)
11. Beigel J. H., Farrar J., Han A. M., Hayden F. G., Hyer R., De Jong M. D., Lochindarat S., Tien N. T. K., Hien N. T., Hien T. T., Nicoll A., Touch S., Yuen K.-Y., Avian influenza A (H5N1) infection in humans. The New England Journal of Medicine 2005 353 13 1374 1385 2-s2.0-25444432780 10.1056/NEJMra052211 (Pubitemid 41362705)
12. Ge Y., Wu B., Qi X., Zhao K., Guo X., Rapid and sensitive detection of novel avian-origin influenza A, (H7N9) virus by reverse transcription loop- mediated isothermal amplification combined with a lateral- flow device. PLoS ONE 2013 8 8, article e69941
13. Zhirnov O. P., Ikizler M. R., Wright P. F., Cleavage of influenza A virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. Journal of Virology 2002 76 17 8682 8689 2-s2.0-0036337409 10.1128/JVI.76.17.8682-8689.2002 (Pubitemid 34864063)
14. Both G. W., Sleigh M. J., Cox N. J., Kendal A. P., Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. Journal of Virology 1983 48 1 52 60 2-s2.0-0020629723 (Pubitemid 13006721)
15. Gocník M., Fislová T., Mucha V., Sládková T., Russ G., Kostolanský F., Varečková E., Antibodies induced by the HA2 glycopolypeptide of influenza haemagglutinin improve recovery from influenza A virus infection. Journal of General Virology 2008 89 4 958 967 2-s2.0-45549102325 10.1099/vir.0.83524-0
16. Ekiert D. C., Friesen R. H. E., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H. J. W. M., Brandenburg B., Vogels R., Brakenhoff J. P. J., Kompier R., Koldijk M. H., Cornelissen L. A. H. M., Poon L. L. M., Peiris M., Koudstaal W., Wilson I. A., Goudsmit J., A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011 333 6044 843 850 2-s2.0-80051635697 10.1126/science.1204839
17. Corti D., Voss J., Gamblin S. J., Codoni G., Macagno A., Jarrossay D., Vachieri S. G., Pinna D., Minola A., Vanzetta F., Silacci C., Fernandez-Rodriguez B. M., Agatic G., Bianchi S., Giacchetto-Sasselli I., Calder L., Sallusto F., Collins P., Haire L. F., Temperton N., Langedijk J. P. M., Skehel J. J., Lanzavecchia A., A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011 333 6044 850 856 2-s2.0-80051670323 10.1126/science.1205669
18. Okuno Y., Isegawa Y., Sasao F., Ueda S., A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. Journal of Virology 1993 67 5 2552 2558 2-s2.0-0027471177 (Pubitemid 23118850)
19. Gocník M., Fislová T., Sládková T., Mucha V., Kostolanský F., Varečková E., Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection. Journal of General Virology 2007 88 3 951 955 2-s2.0-33847623088 10.1099/vir.0.82563-0 (Pubitemid 46359566)
20. Pica N., Hai R., Krammer F., Wang T. T., Maamary J., Eggink D., Tan G. S., Krause J. C., Moran T., Stein C. R., Banach D., Wrammert J., Belshe R. B., García-Sastre A., Palese P., Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proceedings of the National Academy of Sciences of the United States of America 2012 109 7 2573 2578 2-s2.0-84863115945 10.1073/pnas. 1200039109
21. Steel J., Lowen A. C., Wang T. T., Yondola M., Gao Q., Haye K., García-Sastre A., Palesea P., Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio 2010 1 1, article e00018-10 2-s2.0-79952140653 10.1128/mBio.00018-10
22. Eggink D., Goff P. H., Palese P., Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. Journal of Virology 2014 88 1 699 704
23. Wang T. T., Tan G. S., Hai R., Pica N., Ngai L., Ekiert D. C., Wilson I. A., García-Sastre A., Moran T. M., Palese P., Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proceedings of the National Academy of Sciences of the United States of America 2010 107 44 18979 18984 2-s2.0-78649953803 10.1073/pnas.1013387107
24. Bommakanti G., Citron M. P., Hepler R. W., Callahan C., Heidecker G. J., Najar T. A., Lu X., Joyce J. G., Shiver J. W., Casimiro D. R., Meulen J. T., Liang X., Varadarajan R., Design of an HA2-based escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proceedings of the National Academy of Sciences of the United States of America 2010 107 31 13701 13706 2-s2.0-77956379133 10.1073/pnas.1007465107
25. Stanekova Z., Mucha V., Sládková T., Blaš kovičová H., Kostolanský F., Varečková E., Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection. Influenza and other Respiratory Viruses 2012 6 6 389 395 2-s2.0-84867708139 10.1111/j.1750-2659.2011.00328.x
26. Krammer F., Pica N., Hai R., Margine I., Palese P., Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. Journal of Virology 2013 87 12 6542 6550
27. Margine I., Krammer F., Hai R., Heaton N. S., Tan G. S., Andrews S. A., Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. Journal of Virology 2013 87 19 10435 10446
28. Throsby M., van den Brink E., Jongeneelen M., Poon L. L. M., Alard P., Cornelissen L., Bakker A., Cox F., van Deventer E., Guan Y., Cinatl J., ter Meulen J., Lasters I., Carsetti R., Peiris M., de Kruif J., Goudsmit J., Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 2008 3 12 2-s2.0-58049198443 10.1371/journal.pone.0003942 e3942
29. Dreyfus C., Laursen N. S., Kwaks T., Zuijdgeest D., Khayat R., Ekiert D. C., Lee J. H., Metlagel Z., Bujny M. V., Jongeneelen M., Van Der Vlugt R., Lamrani M., Korse H. J. W. M., Geelen E., Sahin Ö., Sieuwerts M., Brakenhoff J. P. J., Vogels R., Li O. T. W., Poon L. L. M., Peiris M., Koudstaal W., Ward A. B., Wilson I. A., Goudsmit J., Friesen R. H. E., Highly conserved protective epitopes on influenza B viruses. Science 2012 337 6100 1343 1348 2-s2.0-84866122029 10.1126/science.1222908
30. Lee J. S., Chowdhury M. Y., Moon H. J., The highly conserved HA2 protein of the influenza a virus induces across protective immune response. Journal of Virological Methods 2013 194 1-2 280 288
31. Stanekova Z., Adkins I., Kosová M., Janulíková J., Šebo P., Varečková E., Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin. Antiviral Research 2013 97 1 24 35 2-s2.0-84870382373 10.1016/j.antiviral.2012.09.008
32. DiLillo D. J., Tan G. S., Palese P., Ravetch J. V., Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc γ R interactions for protection against influenza virus in vivo. Nature Medicine 2014 20 143 151
33. Wolff J. A., Malone R. W., Williams P., Wang Chong W. C., Acsadi G., Jani A., Felgner P. L., Direct gene transfer into mouse muscle in vivo. Science 1990 247 4949 1465 1468 2-s2.0-0025231388
34. Dhama K., Mahendran M., Gupta P. K., Rai A., DNA vaccines and their applications in veterinary practice: current perspectives. Veterinary Research Communications 2008 32 5 341 356 2-s2.0-43249111930 10.1007/s11259-008-9040-3
35. Laddy D. J., Yan J., Corbitt N., Kobasa D., Kobinger G. P., Weiner D. B., Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 2007 25 16 2984 2989 2-s2.0-33947604318 10.1016/j.vaccine.2007.01.063 (Pubitemid 46482729)
36. Hillaire M. L. B., Osterhaus A. D. M. E., Rimmelzwaan G. F., Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. Journal of Biomedicine and Biotechnology 2011 2011 12 2-s2.0-84855175221 10.1155/2011/939860 939860
37. Dai J., Pei D., Wang B., Kuang Y., Ren L., Cao K., Zuo B., Shao J., Li S., Jiang Z., Li H., Li M., A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. Virology Journal 2013 10, article 40 2-s2.0-84873026187 10.1186/1743-422X-10-40
38. Lambert L. C., Fauci A. S., Influenza vaccines for the future. The New England Journal of Medicine 2010 363 21 2036 2044 2-s2.0-78549241668 10.1056/NEJMra1002842
39. Wright P. F., Neumann G., Kawaoka Y., Knipe D. M., Howley M., Orthomyxoviruses. Fields Virology 2006 1 5th Philadelphia, Pa, USA Lippincott Williams & Wilkins
40. Buxton Bridges C., Thompson W. W., Meltzer M. I., Reeve G. R., Talamonti W. J., Cox N. J., Lilac H. A., Hall H., Klimov A., Fukuda K., Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. Journal of the American Medical Association 2000 284 13 1655 1663 2-s2.0-0034605496
41. Kumar P., Khanna M., Kumar B., Rajput R., Banerjea A. C., A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge. Antiviral Research 2012 93 1 78 85 2-s2.0-84355166402 10.1016/j.antiviral.2011.10.021